Amend 010 - PERTUSSIS VACCINES - GlaxoSmithKline Inc.

Status Awarded

Contract number E60PH-21PERT/002/PH

Solicitation number E60PH-21PERT

Publication date

Contract award date

Last amendment date

Amendment value

CAD 18,699,776.08
Description
This contract was awarded to:
GlaxoSmithKline Inc.
Pertussis containing vaccines
Business address
100 Milverton Drive Suite 800
Mississauga, Ontario, L5R 4H1
CA
Notice type
Not Applicable
Language(s)
English
,
French
Selection criteria
Lowest Price

View the full contract history for GlaxoSmithKline Inc..

Contract duration

The contract will be for a period of 62 month(s), from 2021/01/05 to 2026/03/31.

Total value of contract

This is the total value of this contract, which includes the initial contract value and the sum of all amendments.

CAD 69,222,397.88

Commodity - UNSPSC

  • 51000000 - Drugs and Pharmaceutical Products

Trade agreements

  • Canadian Free Trade Agreement (CFTA)

Reason for limited tendering

A contracting officer can use limited tendering for specific reasons outlined in the applicable trade agreements. The reason for this contract is described below:

  • None
Contact information

Contracting organization

Organization
Department of Public Works and Government Services (PSPC)
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Contracting authority
Chan, Lina (SPAC/PSPC) (elle-la / she-her)
Email
lina.chan@tpsgc-pwgsc.gc.ca

Buying organization(s)

Organization
Department of Public Works and Government Services (PSPC)
Address
11 Laurier St, Phase III, Place du Portage
Gatineau, Quebec, K1A 0S5
Canada
Date modified: